Lucid Diagnostics (LUCD)
(Delayed Data from NSDQ)
$1.00 USD
+0.02 (2.19%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.00 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Lucid Diagnostics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Instruments industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
LUCD 1.00 +0.02(2.19%)
Will LUCD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LUCD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LUCD
Hologic (HOLX) Q3 Earnings and Revenues Beat Estimates
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Lags Revenue Estimates
LUCD: What are Zacks experts saying now?
Zacks Private Portfolio Services
908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates
Stereotaxis Inc. (STXS) Reports Q1 Loss, Tops Revenue Estimates
Will Lucid Diagnostics Inc. (LUCD) Report Negative Earnings Next Week? What You Should Know
Other News for LUCD
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 | ...
Lucid Diagnostics (LUCD) Awaits Medicare Coverage for EsoGuard Test
Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG
Lucid Diagnostics (LUCD) Set for Boost with Upcoming Medicare Approval
BTIG buyers of Lucid Diagnostics ahead of Medicare coverage